تقرير
Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease
| العنوان: | Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease |
|---|---|
| المساهمون: | Ri-Bao Wei, Nephrology |
| المصدر: | Satapoj B, LeelasK, Supasyndh O, Choovhn P. Short-term admtratn of an angtens receptor blocker patnts wh long-term hemodlys patnts proves sul restance. J Med Assoc Tha 2014 Jun;97(6):574-81. Usha K, Takuma M, Ando H, hawa-KobayashE, Nozawa M, Maekawa T, Sha T, Fujura A. Effects of telmartan and valsartan on sul sensy obese dbet me. Eur J Pharmacol. 2013 Jan 5;698(1-3):505-10. do 10.1016/j.ejphar.2012.11.022. Epub 2012 Nov 27. asha M, Sakoda H, Kushama A, Fujho M, Ohno H, Nakatsu Y, Fukusha T, Kumamoto S, Tsucha Y, KuchT, Kurara H, Akazawa H, Komuro Kamata H, Nhura F, Asano T. Valsartan, dependently of AT1 receptor or PPARgamma, suppresses LPS-duced macrophage actatn and proves sul restance cocultured adocytes. Am J Physl Endocrol Metab. 2012 Feb 1;302(3):E286-96. do 10.1152/ajpendo.00324.2011. Epub 2011 Nov 1. Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease |
| الوصول الحر: | https://clinicaltrials.gov/ct2/show/NCT02299310Test |
| قاعدة البيانات: | ClinicalTrials.gov |
| الوصف غير متاح. |